Back to search results

Rare Kidney Stone Consortium Biobank

This study is collecting samples from people with rare kidney stone conditions like primary hyperoxaluria (a genetic disorder causing too much oxalate in the body), Dent disease, APRT deficiency, and Cystinuria. Researchers will also collect samples from their family members. The goal is to store these samples in a biobank for future research, which will help us better understand these diseases and develop new treatments to protect kidney function and reduce kidney stone formation. This study aims to collect 2000 samples over four years. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will collect information and samples without giving any specific treatments. It plans to enroll up to 2000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is to measure the number of samples stored in the tissue bank at 4 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02026388

Rare Kidney Stone Consortium Biobank

Recruiting
Not specifiedAll AgesObservational
Mayo Clinic
~2,000 participants
Updated 2026-07-22 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of samples stored in tissue bank
Measured over 4 years

Conditions

Primary Hyperoxaluria
Dent Disease
APRT Deficiency
Cystinuria

Explore related trials

Adenine Phosphoribosyltransferase DeficiencyCystinuriaDent DiseasePrimary HyperoxaluriaAGT GeneAGXT GeneAPRT GeneCLCN5 GeneGlucocorticoid Receptor

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • John C Lieske, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Barb M Seide
[email protected]
507-255-0387
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of primary hyperoxaluria (PH) meeting one or more of the following criteria:
Diagnosis of Dent disease meeting one or more of the following criteria:
Diagnosis of APRT disease meeting one or more of the following criteria:
Diagnosis of Cystinuria meeting one or more of the following criteria:
Relative of someone with confirmed primary hyperoxaluria, Dent disease, APRT deficiency (also known as dihydroxyadeninuria), or cystinuria

What this trial measures

  • Number of samples stored in tissue bank4 years

    encourage more research